Diabetes Mellitus, Type 1

• The Third Affliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China

• Diabetes Research Center — Odense, Denmark

Not specified

• Ainshams university pediatric's hospital — Cairo, Egypt

• Souseikai Hakata Clinic — Fukuoka, Fukuoka, Japan
• Nishikumamoto Hospital — Kumamoto, Kumamoto, Japan
• Shinjuku Research Park Clinic — Tokyo, Shinjyuku-ku, Japan
• SOUSEIKAI Sumida Hospital — Tokyo, Sumida-ku, Japan

• University of Colorado Denver — Aurora, Colorado, United States
• International Diabetes Center at Park Nicollet — Minneapolis, Minnesota, United States
• International Diabetes Centre at Park Nicollet — Minneapolis, Minnesota, United States
• University of Cambridge — Cambridge, United Kingdom

• Novo Nordisk Investigational Site — Guntur, Andhra Pradesh, India
• Novo Nordisk Investigational Site — Vijayawada, Andhra Pradesh, India
• Novo Nordisk Investigational Site — Visakhapatnam, Andhra Pradesh, India
• Novo Nordisk Investigational Site — Ahmedabad, Gujarat, India

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Sacramento, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Walnut Creek, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Aurora, Colorado, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Denver, Colorado, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Aurora, Colorado, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Miami, Florida, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Atlanta, Georgia, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Idaho Falls, Idaho, United States

• Novo Nordisk Investigational Site — Graz, Austria